Eli Lilly & Co. (LLY), Alkermes Plc (ALKS): The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter)
Eli Lilly & Co.
Alkermes Inc (Old) (ALKS)
Market is closed
News
- First
- << Previous
- 61 - 67
Alkermes Plc (ALKS): Insiders Aren't Crazy About It
In today’s marketplace, there are many indicators market participants can use to analyze publicly traded companies. A pair of the most innovative are hedge fund and insider trading sentiment.
Valeant Pharmaceuticals Intl Inc (VRX): Hedge Funds and Insiders Are Bullish, What Should You Do?
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in 37 hedge funds' portfolio at the end of March. VRX shareholders have witnessed an increase in enthusiasm from smart money recently.
Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech - Part Two
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Alkermes Plc (ALKS), Pfizer Inc. (PFE), Eli Lilly & Co. (LLY): These Biotech Investors Are Far From Depressed
The drug produced a statistically significant improvement in three different rating scales for depression compared to placebo.
Alkermes Plc (NASDAQ:ALKS): Insiders Are Buying, Should You?
Alkermes Plc (NASDAQ:ALKS) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012. ALKS has seen a decrease in support from the world's most elite money managers in recent months.
Has Elan Corporation, plc (ADR) (ELN) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
- First
- << Previous
- 61 - 67
Billionaire Hedge Funds
